Acute injection of drugs with low addictive potential (Δ9- tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine)

Molecular Brain Research

Volumn 71, Issue 2, 1999, Pages 313-324

  Erdtmann Vourliotis, Martina ^a   Mayer, Peter ^a   Riechert, Uta ^a   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

C fos; Cocaine; In situ hybridization; LSD; MDMA; Morphine; THC

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE; DRONABINOL; LYSERGIDE; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG DEPENDENCE; GENE EXPRESSION; GENE INDUCTION; IN SITU HYBRIDIZATION; INJECTION; LIMBIC CORTEX; MALE; MAMMILLARY BODY; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; COCAINE; HALLUCINOGENS; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; LYSERGIC ACID DIETHYLAMIDE; MALE; MORPHINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NARCOTICS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; STREET DRUGS; TETRAHYDROCANNABINOL;

ANIMALIA;

EID: 0032694635     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00207-7     Document Type: Article

References (35)

1. Carboni E., Imperato A., Perezzani L., DiChiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of free moving rats. Neuroscience. 28:1989;653-661.
2. Curran E.J., Akil H., Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochemical Research. 21:1996;1425-1435.
3. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids: I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7181-7188.
4. DiChiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely-moving rats. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5274-5278.
5. Dragunow M., Logan B., Laverty R. 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur. J. Pharmacol. 206:1991;255-258.
6. Erdtmann-Vourliotis M., Mayer P., Riechert U., Grecksch G., Höllt V. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats. Mol. Brain Res. 61:1998;51-61.
7. Erdtmann-Vourliotis M., Mayer P., Riechert U., Händel M., Kriebitzsch J., Höllt V. Rational design of oligonucleotide probes to avoid optimization steps in in situ hybridization. Brain Res. Protoc. 4:1999;82-91.
8. M. Erdtmann-Vourliotis, P. Mayer, R. Linke, U. Riechert, V. Höllt, Long-lasting sensitization towards morphine in motoric and limbic areas as determined by c-fos expression in rat brain, Mol. Brain Res. (1999, in press).
9. G. Halliday, A. Harding, G. Paxinos, Serotonin and tachykinin systems, in: G. Paxinos (Ed.), The Rat Nervous System, 2nd edn., Academic Press, San Diego, 1995.
10. Herz A. Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharmacol. 76:1998;252-258.
11. Höllt V. Opioid peptide processing and receptor selectivity. Annu. Rev. Pharmacol. Toxicol. 26:1986;59-77.
12. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
13. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berlin). 98:1989;357-362.
14. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8537-8541.
15. Mailleux P., Verslype M., Preud'homme X., Vanderhaeghen J.J. Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain. NeuroReport. 5:1994;1265-1268.
16. McGregor I.S., Arnold J.C., Weber M.F., Topple A.N., Hunt G.E. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. Brain Res. 802:1998;19-26.
17. Meehan S.M., Schechter M.D. LSD produces conditioned place preference in male but not female fawn hooded rats. Pharmacol. Biochem. Behav. 59:1998;105-108.
18. Milner P.M. Brain-stimulation reward: a review. Can. J. Psychol. 45:1991;1-36.
19. Miyamoto A., Yamamoto T., Ohno M., Watanabe S., Tanaka H., Morimoto S., Shoyama Y. Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain. Brain Res. 710:1996;234-240.
20. Moratalla R., Vallejo M., Elibol B., Graybiel A.M. D1-class dopamine receptors influence cocaine-induced persistent expression of FOS-related proteins in striatum. NeuroReport. 8:1996;1-5.
21. Nestler E.J., Berhow M.T., Brodkin E.S. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Molecular Psychiatry. 1:1996;190-199.
22. O'Brien, Drug addiction and drug abuse, in: J.G. Hardman, A. Goodman Gilman, L.E. Limbird (Eds.), Goodman and Gilman's: The pharmacological basis of therapeutics, 9th edn., McGraw-Hill, New York, 1996, pp. 557-577.
23. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 3rd edn., Academic Press, San Diego, 1997.
24. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:1997;129-180.
25. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., van Huijsduijnen R.H., Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science. 275:1997;83-86.
26. Porcella A., Gessa G.L., Pani L. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain. Eur. J. Neurosci. 10:1998;1743-1751.
27. Rudnick G., Wall S.C. The molecular mechanism of 'ecstasy' [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1817-1821.
28. Schechter M.D. Serotonergic-dopaminergic mediation of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol. Biochem. Behav. 31:1988;817-824.
29. Schechter M.D. 'Candyflipping': synergistic discriminative effect of LSD and MDMA. Eur. J. Pharmacol. 341:1998;131-134.
30. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
31. Spanagel R. Modulation of drug induced sensitization processes by endogenous opioid systems. Behav. Brain Res. 70:1995;37-49.
32. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., Kreek M.J. Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. NeuroReport. 7:1996;2196-2200.
33. Vezina P., Kalivas P.W., Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 417:1987;51-58.
34. Wickelgren I. Getting the brain's attention. Science. 278:1997;35-37.
35. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-255.